Spinal Cord Injury Cervical Clinical Trial
Official title:
Effectiveness Analysis of Armeo Spring Device as a Rehabilitation Treatment in Spinal Cord Injured Patients
Verified date | April 2022 |
Source | Hospital Nacional de Parapléjicos de Toledo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Loss of motor function is a consequence after a spinal cord injury (SCI). The incidence of SCI varies greatly from 12.1 to 57.8 cases per million depending on the country. More than 50% of people with SCI have impaired upper limb (UL) function, experiencing limitations in performing functional tasks. In this context, one of the rehabilitation objectives is to achieve the maximum level of independence in the patient in the performance of activities of daily living (ADL). Within the clinical setting, the main motivation in the use of robotic devices and/or exoskeletons for a rehabilitation purpose focuses on the fact that these help therapists in administering repetitive manual therapies to patients during exercises. There is evidence that the amount of therapy patients receive is insufficient. Without creating additional time demands on clinicians, robotic devices can perform the repetitive mechanical aspects of therapy, increasing the amount of therapy that patients receive. However, the current evidence in stroke patients suggests that the improvements observed are due to the intensity of the therapy, regardless of whether the administration of rehabilitation is due to robotic devices and/or traditional means. The main objective of this study is to analyze the effectiveness of the commercial Armeo® Spring system (Hocoma AG, Switzerland) and a Virtual Reality application to repeatedly work the ADL from drinking from a glass, in people with cervical SCI. The ADL of drinking has been chosen, as a representative activity of those related to food, which requires control, strength and coordination of the UL. The study is carried out at the Hospital Nacional de Parapléjicos with the collaboration of Occupational Therapy Unit, the Rehabilitation Department, and the Biomechanics and Technical Aids Unit. This effectiveness is measured in terms of functional improvements and in the quality of the UL movements performed.
Status | Completed |
Enrollment | 34 |
Est. completion date | December 28, 2021 |
Est. primary completion date | November 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years to 75 Years |
Eligibility | Inclusion Criteria: - Cervical lesions above C8, incomplete in the motor aspect or complete with zones of partial motor preservation at least C6, classified according to the ASIA scale. - Traumatic or non-progressive medical etiology. - Less than 6 months of injury evolution (subacute). - Age between 16 and 75 years. - To have reached the seated posture. - Be informed and consent to participate in the study. Exclusion Criteria: - Unstable orthopaedic injuries such as unconsolidated fractures or with unstable osteosynthesis systems in upper limbs. - Skin lesions and/or pressure ulcers in the exoskeleton placement area. - Having joint stiffness and/or severe spasticity. - Bronchopneumopathy and/or severe heart disease that will require monitoring during exercise. - Visual problems. - Cognitive impairment. - Do not sign the corresponding informed consent. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Nacional de Parapléjicos | Toledo |
Lead Sponsor | Collaborator |
---|---|
Hospital Nacional de Parapléjicos de Toledo |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Clinical scale SCIM | The Spinal Cord Independence Measure (SCIM) is a new disability scale developed specifically for patients with spinal cord lesions in order to make the functional assessments of patients with paraplegia or tetraplegia more sensitive to changes. Exclusively designed for spinal injury. It consists of 3 subscales. The total score varies from 0-100 points, where 0 corresponds to the highest degree of dependency and 100 to the highest degree of independence. | At baseline | |
Primary | Change from baseline Clinical scale SCIM at 10 weeks | The Spinal Cord Independence Measure (SCIM) is a new disability scale developed specifically for patients with spinal cord lesions in order to make the functional assessments of patients with paraplegia or tetraplegia more sensitive to changes. Exclusively designed for spinal injury. It consists of 3 subscales. The total score varies from 0-100 points, where 0 corresponds to the highest degree of dependency and 100 to the highest degree of independence. | At the end of the study (at week 10) | |
Primary | Clinical scale CUE | Capabilities of Upper Extremity (CUE) measures upper extremity functional limitations in individuals with tetraplegia. The patient reports the outcome about how well you are able to use the arms and hands of patients. 32 item questionnaire with items in 7 domains. Self-reported measure performed by interview.
Score on 7 points scale representing self-perceived difficulty: 1 (Totally limited, can´t do at all) y 7 (Not at all limited). So, the minimum score is 32 (worse result) and the maximum score 224 (greater function) |
At baseline | |
Primary | Change from baseline Clinical scale CUE at 10 weeks | Capabilities of Upper Extremity (CUE) measures upper extremity functional limitations in individuals with tetraplegia. The patient reports the outcome about how well you are able to use the arms and hands of patients. 32 item questionnaire with items in 7 domains. Self-reported measure performed by interview.
Score on 7 points scale representing self-perceived difficulty: 1 (Totally limited, can´t do at all) y 7 (Not at all limited). So, the minimum score is 32 (worse result) and the maximum score 224 (greater function) |
At the end of the study (at week 10) | |
Primary | Clinical Scale Jebsen-Taylor Hand Function (JTHF) | The Jebsen-Taylor function test was designed to provide a short, objective test of hand functions commonly used in activities of daily living (ADLs). The target patient population includes adults with neurological or musculoskeletal conditions involving hand disabilities, although there may be other patient populations with other hand dysfunctions which may be appropriate. It consists of seven items that include a range of fine motor, weighted and non-weighted hand function activities which are timed: writing (copying) a 24-letter sentence turning over a 3 × 5" cards, picking up small common objects such as a coin and bottle cap, simulated feeding using a teaspoon and five kidney beans, stacking checkers picking up large light objects such as an empty tin can, and picking up and moving large weighted cans. The scale measures the time in seconds in reaching each task. A higher spent time is a worse outcome. | At baseline | |
Primary | Change from baseline Clinical Scale Jebsen-Taylor Hand Function (JTHF) at 10 weeks | The Jebsen-Taylor function test was designed to provide a short, objective test of hand functions commonly used in activities of daily living (ADLs). The target patient population includes adults with neurological or musculoskeletal conditions involving hand disabilities, although there may be other patient populations with other hand dysfunctions which may be appropriate. It consists of seven items that include a range of fine motor, weighted and non-weighted hand function activities which are timed: writing (copying) a 24-letter sentence turning over a 3 × 5" cards, picking up small common objects such as a coin and bottle cap, simulated feeding using a teaspoon and five kidney beans, stacking checkers picking up large light objects such as an empty tin can, and picking up and moving large weighted cans. The scale measures the time in seconds in reaching each task. A higher spent time is a worse outcome. | At the end of the study (at week 10) | |
Primary | Clinical scale Nine Hole Peg Test | The Nine-Hole Peg Test (9-HPT) is a standardized, quantitative assessment used to measure finger dexterity. The scale measures the time in seconds in reaching each task. A higher spent time is a worse outcome. | At baseline | |
Primary | Change from baseline Clinical scale Nine Hole Peg Test at 10 weeks | The Nine-Hole Peg Test (9-HPT) is a standardized, quantitative assessment used to measure finger dexterity. The scale measures the time in seconds in reaching each task. A higher spent time is a worse outcome. | At the end of the study (at week 10) | |
Primary | Clinical Scale GRASSP | The GRASSP is a clinical impairment measure specific to the upper limb for use after tetraplegia. The GRASSP measure sensorimotor and prehension function through three domains, important in describing arm and hand function: Strength, Sensation, Prehension. The minimal score is 0 (worse outcome) and the maximum 98 (better outcome) for each hand. | At baseline | |
Primary | Change from baseline Clinical Scale GRASSP at 10 weeks | The GRASSP is a clinical impairment measure specific to the upper limb for use after tetraplegia. The GRASSP measure sensorimotor and prehension function through three domains, important in describing arm and hand function: Strength, Sensation, Prehension. The minimal score is 0 (worse outcome) and the maximum 98 (better outcome) for each hand. | At the end of the study (at week 10) | |
Primary | Edinburg Handedness Test | Most people are right handed. The Edinburgh Handedness Inventory is a well known short questionnaire for determining objectively whether one is left or right handed and there is a short form of it. 10 items are valued. The total score is 50 points and the minimum 10 points. The closer score to 50 points, more left-handed the person is. And the closer score to 10 the more right-handed. | At baseline | |
Primary | Kinematic indices | This assessment is performed by means of photogrammetry. Markers are placed on the trunk and the arm analyzed, and kinematic variables about the UL movement are computed in terms of accuracy, agility, coordination, efficiency and smoothness. A score of 100 in each index corresponds to the healthy pattern. The minimun and worse outcome is 0 score. | At baseline | |
Primary | Change from baseline Kinematic indices at 10 weeks | This assessment is performed by means of photogrammetry. Markers are placed on the trunk and the arm analyzed, and kinematic variables about the UL movement are computed in terms of accuracy, agility, coordination, efficiency and smoothness. A score of 100 in each index corresponds to the healthy pattern. The minimun and worse outcome is 0 score. | At the end of the study (at week 10) | |
Secondary | Compliance | The total sessions number that the patient has performed and the duration in weeks | At the end of the study (at week 10) | |
Secondary | QUEST usability scale | At ending the treatment using Armeo Spring, patients show their opinion and satisfaction level with the experimental scenario | At the end of the study (at week 10) | |
Secondary | TMS assessment | A transcranial magnetic stimulation-based assessment is made. | At baseline | |
Secondary | Change from baseline TMS assessment at 10 weeks | A transcranial magnetic stimulation-based assessment is made. | At the end of the study (at week 10) | |
Secondary | Beck's Depression Inventory | This depression inventory can be self-scored. The scoring scale is at the end of questionnaire. the BDI consists of 21 items, self-reporting inventory for assessing depression, with 4 alternatives each that are rated from 0 to 3, giving a possible total of 0 to 63 points. The interpretation of the score is as follows: From 1-10 points: These ups and downs are considered normal; from 11-16 points: Slight disturbance of mood; from 17-20 points: Intermittent states of depression. From 21-30 points: Moderate depression. 31-40 points: Severe depression; More than 40 points: Extreme depression. | At baseline | |
Secondary | Change from baseline Beck's Depression Inventory at 10 weeks | This depression inventory can be self-scored. The scoring scale is at the end of questionnaire. the BDI consists of 21 items, self-reporting inventory for assessing depression, with 4 alternatives each that are rated from 0 to 3, giving a possible total of 0 to 63 points. The interpretation of the score is as follows: From 1-10 points: These ups and downs are considered normal; from 11-16 points: Slight disturbance of mood; from 17-20 points: Intermittent states of depression. From 21-30 points: Moderate depression. 31-40 points: Severe depression; More than 40 points: Extreme depression. | At the end of the study (at week 10) | |
Secondary | Hospital Anxiety and Depression Scale (HADS) | The HADS is a questionnaire widely used to evaluate the anxiety and depression. The HADS takes between 2 to 5 minutes to complete. The HAD contains seven subscales for each mood (anxiety and depression). The HAD Scale is an effective screening instrument and ranges of scores are given in order that the proportion of false positives or false negatives may be minimized. Regarding the scores obtained, a score equal to or greater than 11 is considered depression/anxiety. Between 0 and 7 is not considered depression/anxiety, and between 8 and 10 is doubtful case. | At baseline | |
Secondary | Change from baseline Hospital Anxiety and Depression Scale (HADS) at 10 weeks | The HADS is a questionnaire widely used to evaluate the anxiety and depression. The HADS takes between 2 to 5 minutes to complete. The HAD contains seven subscales for each mood (anxiety and depression). The HAD Scale is an effective screening instrument and ranges of scores are given in order that the proportion of false positives or false negatives may be minimized. Regarding the scores obtained, a score equal to or greater than 11 is considered depression/anxiety. Between 0 and 7 is not considered depression/anxiety, and between 8 and 10 is doubtful case. | At the end of the study (at week 10) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03680872 -
Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System
|
N/A | |
Not yet recruiting |
NCT06437548 -
Epidural Stimulation for Upper Extremity Function
|
N/A | |
Completed |
NCT03385005 -
Evaluating Neuromuscular Stimulation for Restoring Hand Movements
|
Early Phase 1 | |
Completed |
NCT05054803 -
Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury
|
Phase 1/Phase 2 | |
Recruiting |
NCT02983955 -
UPNRIDE Powered Wheelchair for Individuals With Walking Impairment: Evaluation of Safety and Usability
|
N/A | |
Recruiting |
NCT05390853 -
Active tDCS Versus Sham tDCS for Upper Limb Recovery in Incomplete Tetraplegic Patients
|
N/A | |
Recruiting |
NCT03048331 -
Functional Electrical Stimulation (FES) and Reconstructive Tetraplegia Hand and Arm Surgery
|
N/A | |
Not yet recruiting |
NCT04465825 -
Developing Strategies to Optimize the Exercise Response After Tetraplegia.
|
N/A | |
Active, not recruiting |
NCT05462925 -
Prediction of Muscle Responsiveness to FES Therapy
|
N/A | |
Completed |
NCT04523636 -
Evaluation of Splinting in Tetraplegia
|
N/A | |
Recruiting |
NCT04276181 -
Combined Nerve and Tendon Transfer for the Restoration of Hand Function in Individuals With Tetraplegia
|
||
Recruiting |
NCT04641793 -
BoMI for Muscle Control
|
N/A | |
Recruiting |
NCT05863754 -
Grasp-Release Assessment of a Networked Neuroprosthesis Device
|
N/A | |
Withdrawn |
NCT04142814 -
Randomized Controlled Study on T-PEP Versus IPV Method for Lower Respiratory Airways Clearance in Tetraplegic Tracheotomized Spinal Cord Injured Patients
|
N/A | |
Active, not recruiting |
NCT03184792 -
Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury
|
N/A | |
Recruiting |
NCT02329652 -
Multi-functional Neuroprosthetic System for Restoration of Motor Function in Spinal Cord Injury
|
N/A | |
Enrolling by invitation |
NCT04369131 -
Controlling Orthostatic Hypotension in People With Cervical Spinal Cord Injury
|
N/A | |
Completed |
NCT06159946 -
Access-H20 Faucet for Spinal Cord Injury
|
N/A | |
Completed |
NCT03239301 -
Robotic-assisted Upper Extremity Training in Spinal Cord Injury Patients
|
N/A | |
Completed |
NCT05362422 -
PAS for Post-SCI Neuropathic Pain
|
N/A |